Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors

BACKGROUND: Osteoarthritis (OA) is one of the main causes of disability worldwide, especially in persons >55 years of age. Currently, controversy remains about the best therapeutic alternative for this disease when evaluated from a cost-effectiveness viewpoint. For Social Security Institutions in...

Descripción completa

Detalles Bibliográficos
Autores principales: Contreras-Hernández, Iris, Mould-Quevedo, Joaquín F, Torres-González, Rubén, Goycochea-Robles, María Victoria, Pacheco-Domínguez, Reyna Lizette, Sánchez-García, Sergio, Mejía-Aranguré, Juan Manuel, Garduño-Espinosa, Juan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626578/
https://www.ncbi.nlm.nih.gov/pubmed/19014495
http://dx.doi.org/10.1186/1478-7547-6-21

Ejemplares similares

Ejemplares similares